Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane’ or ‘the Company’) is pleased to announce the latest ...
AI hype has triggered millions of people and many corporations to dabble in AI with some launching full-blown applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results